Remedy Robotics, a San Francisco-based medical robotics company, has raised $62 million in Series B funding to advance its AI-enabled N1 System for cardiovascular and neurovascular procedures.
The funding will support clinical trials, regulatory approval efforts and further development of the robotic platform, which is designed to enable endovascular procedures through on-site, remote and potentially autonomous operation.
The round was led by DCVC, with participation from UC Investments, Skip Capital and Hostplus. Existing investors, including Build Collective, Blackbird, Divergent Capital and KdT Ventures, also participated. [Read more…] about Remedy Robotics raises $62 million to advance AI-powered cardiovascular surgery robot
